Treatment
Clemastine Fumarate clinical trials
We’re tracking 5 recruiting studies that include Clemastine Fumarate, each written for real people, not researchers, below.
Recruiting studies
- NCT07304024RecruitingPhase 1/Phase 2
Testing a drug and sound therapy for age-related hearing difficulty
This trial tests whether a combination of an antihistamine (clemastine fumarate) and specially designed sounds can improve how the brain processes hearing in middle-aged adults with mild hearing loss. It might help if you have trouble understanding speech in noisy settings.
Aurora, ColoradoAges 45–65 - NCT05359653RecruitingPhase 1/Phase 2
Clemastine to study MRI changes in relapsing MS
This early-phase study tests whether clemastine (a drug being studied for “myelin repair”) changes how MS looks on special MRI scans. It may help researchers understand if the treatment supports restoring nerve covering in people with relapsing-remitting MS.
San Francisco, CaliforniaAges 18–55 - NCT02521311RecruitingPhase 2
Clemastine to help restore nerve covering in optic neuritis
This Phase 2 trial tests whether clemastine can help regrow the protective covering around the optic nerve after acute optic neuritis (an inflammation-related vision problem). It may help improve vision recovery and signal how well “remyelination” happens.
San Francisco, CaliforniaAges 18–55 - NCT06591091RecruitingPhase 2
Clemastine for Depression in Older Adults
This study tests if adding clemastine (an allergy medication) to standard antidepressants can improve brain health and boost treatment response in adults over 60 with depression.
Chicago, IllinoisAges 60 years+ - NCT07688746RecruitingPhase 1
Helping premature babies heal brain injury
This trial tests a treatment for brain injury in premature babies born before 32 weeks. It aims to protect and repair white matter, the part of the brain that helps nerve cells communicate.
San Francisco, CaliforniaAges 3 weeks–5 months
What Clemastine Fumarate is being studied for
Conditions with recruiting Clemastine Fumarate studies.
Common questions
- Are there clinical trials studying Clemastine Fumarate?
- Yes. Clin2 currently lists 5 recruiting studies that include Clemastine Fumarate, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Clemastine Fumarate trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Clemastine Fumarate an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Clemastine Fumarate or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.